Same peptide, different counter-ion. See how TFA and acetate salts differ on net peptide content, residual counter-ion specs, and price per milligram.
BPC-157 and BPC-157 acetate are the same peptide sequence — the difference is the counter-ion left behind after purification. "BPC-157" sold as a research reference material is almost always the acetate salt already; the label just omits it. During reverse-phase HPLC purification, trifluoroacetic acid (TFA) is the standard ion-pairing modifier, and the peptide comes off the column as a TFA salt. A vendor selling "BPC-157 acetate" has run an additional ion-exchange step to swap TFA for acetate. So the real comparison is not two molecules — it is TFA salt vs. acetate salt, and it shows up in three places on your paperwork: net peptide content, counter-ion residual specs, and price per milligram of actual peptide.
BPC-157 is a 15-residue partial sequence (GEPPPGKPADDAGLV) with a free-base molecular weight of roughly 1419.5 Da. That number does not change between the two products. What changes is what is bound to the basic sites — the N-terminal amine and the lysine side chain — after lyophilization.
A 5 mg vial of TFA-salt BPC-157 at 18% counter-ion and water content contains roughly 4.1 mg of actual peptide. The same 5 mg vial as a well-specified acetate salt at 5% total counter-ion plus 4% water might contain 4.55 mg. That is an 11% difference in delivered material for a product that looks identical on the label.
Purity by HPLC is the headline number, and it is the least informative one in this comparison. A 99.1% HPLC purity result is a statement about the relative peak area of the peptide against other UV-absorbing species at 214 nm. Counter-ion does not absorb meaningfully at that wavelength. You can have a 99% pure peptide that is 22% TFA by mass, and nothing in the chromatogram will tell you.
The documents that distinguish the two products:
If a vendor's COA gives you HPLC purity and a mass spec trace and nothing else, you cannot compute how much peptide you actually bought. That applies to both salt forms equally, and it is the single most common documentation gap across the category. Our quality page details which of these assays accompany each lot.
A purity percentage without a net peptide content figure is a statement about what else is in the vial, not about how much of what you ordered is in it.
There are real, measurable reasons a lab specifies acetate. None of them are about the peptide performing differently — they are about the counter-ion interfering with instrumentation and assays.
If none of these apply to the study design, the counter-ion is largely an accounting problem rather than an experimental one — and it should be handled as one, by adjusting for net peptide content rather than by paying for a salt exchange.
This is the part that costs us sales, and it should be said plainly: most buyers asking this question do not need the acetate form, and a meaningful share of "BPC-157 acetate" listings on the market are the same TFA-salt material with a different label.
Specific reasons to skip it:
The failure mode worth naming: a lab specifies acetate, receives unremediated TFA material with an acetate label, and then attributes an anomalous cell-viability result to the peptide rather than to ~200 µM of TFA they did not know was in the well. The salt form only helps if it is documented and verified.
Lyophilized BPC-157 as either salt is stored at -20 °C for routine holding, with -80 °C for long-horizon archival. Typical vendor shelf-life statements for the lyophilized powder run 24–36 months at -20 °C in a sealed vial protected from light and moisture. Both salt forms behave comparably in the dry state; the practical differences appear on the bench.
Lot-to-lot traceability matters more than salt form for reproducibility. A lot number that ties back to a specific synthesis batch, a dated COA, and retained chromatograms is what lets you explain a discrepancy six months later. Materials sold through this site are supplied strictly for research use only, and lot documentation is issued per batch rather than per order.
Send one email before you buy. Ask for:
1. The net peptide content figure and the method used to obtain it.
2. Residual TFA in % w/w or ppm, with the method — ion chromatography or ¹⁹F NMR.
3. Karl Fischer water content.
4. The lot number on the COA and confirmation that it matches the vial you will receive.
5. Whether the acetate product was produced by ion exchange or by acetate-buffer preparative HPLC.
A supplier that answers all five in writing is worth a 10–20% price premium over one that answers two. A supplier that responds with marketing language about purity without producing numbers has told you what you need to know in about 48 hours, for free. Comparative notes on how vendors in this category document their material are collected in the library.
Treat "BPC-157 vs. BPC-157 acetate" as a documentation question, not a chemistry question. The peptide is the same. The counter-ion changes net peptide content by roughly 10–20%, changes far-UV and ESI-MS behavior materially, and changes cell-culture compatibility in ways that matter if your work goes there. Buy acetate when you have a specific analytical reason and the COA proves the exchange happened. Buy the standard TFA salt otherwise, adjust your mass calculations against a documented net peptide content figure, and put the savings toward a second lot for reproducibility. Questions about lot documentation for a specific batch can go through contact.
Supplied strictly for in-vitro laboratory research by qualified researchers and institutions. Not a drug, food, cosmetic or dietary supplement. Not for human or veterinary consumption. Not evaluated by the FDA.
Purity, identity and lot number, documented for the exact vial you receive.